Diabetes, Vol 38, Issue 10 1217-1225, Copyright © 1989 by American Diabetes Association
Mechanism of IGF-I-stimulated glucose transport in human adipocytes. Demonstration of specific IGF-I receptors not involved in stimulation of glucose transport
MK Sinha, C Buchanan, N Leggett, L Martin, PG Khazanie, R Dimarchi, WJ Pories and JF Caro
Department of Medicine, East Carolina University School of Medicine, Greenville, North Carolina 27858-4354.
We demonstrate the presence of specific insulinlike growth factor I (IGF-I)
receptors in human adipocytes. Competition studies with 125I-labeled IGF-I
and unlabeled IGF-I, IGF-II, and insulin showed the specificity of
125I-IGF-I binding to the IGF-I receptors in adipocytes, membranes, and
partially purified detergent-solubilized extracts. The monoclonal antibody
to the IGF-I receptor (alpha-IR3) inhibits 125I-IGF-I binding and
immunoprecipitates the IGF-I receptor. In addition, the alpha-subunit of
IGF-I receptor is approximately 10,000 Mr larger than the alpha-subunit of
insulin receptor, and IGF-I stimulates phosphorylation of the beta-subunit
of the IGF-I receptor. IGF-I stimulates basal glucose transport in human
adipocytes, but the concentrations of IGF-I required for half-maximal and
maximal stimulation of glucose transport are 800- and 1000-fold greater
than that of insulin. The possibility of IGF-I stimulating glucose
transport by interacting predominantly with insulin receptors is suggested
by data showing that 1) IGF-I competes with insulin-binding sites, 2) there
is a lack of an additive effect with IGF-I and insulin in stimulating
glucose transport, 3) alpha-IR3, which specifically inhibits IGF-I binding,
does not inhibit IGF-I or insulin-stimulated glucose transport, 4)
insulin-receptor antibody MA-10 inhibits IGF-I and insulin-stimulated
glucose transport, and 5) IGF-I stimulates insulin-receptor
autophosphorylation, although its effect is markedly decreased compared
with insulin. In summary, human adipocytes possess specific IGF-I
receptors. However, IGF-I stimulates glucose transport predominantly by
interacting with the insulin receptor.